PEAK6 Group’s MINDRAY MED INTL LTD SPONSORED ADR REPSTG CL A MR Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2016
Q1
Sell
-38,600
Closed -$1.05M 5550
2015
Q4
$1.05M Sell
38,600
-39,800
-51% -$1.03M 0.01% 1890
2015
Q3
$1.72M Sell
78,400
-5,400
-6% -$138K 0.01% 1699
2015
Q2
$2.39M Buy
83,800
+76,500
+1,048% +$2.23M 0.01% 1335
2015
Q1
$200K Buy
+7,300
New +$201K ﹤0.01% 3451
2014
Q1
Sell
-11,900
Closed -$433K 5797
2013
Q4
$433K Buy
+11,900
New +$462K ﹤0.01% 2795

Other funds holding MR

PEAK6 Group's MR Position: Q1 2016 in Review

PEAK6 Group sold out of MINDRAY MED INTL LTD SPONSORED ADR REPSTG CL A (MR) in Q1 2016, closing a stake of 213,149 shares — an estimated $5.78M sold.

PEAK6 Group first reported a position in MR in Q4 2013 and held it in 4 quarters. The position peaked at $5.78M in Q4 2015. 2 funds tracked by Wall St. Rank hold MR as of Q1 2016.

  • PEAK6 Group reported no remaining MINDRAY MED INTL LTD SPONSORED ADR REPSTG CL A position as of Q1 2016 after selling out during the quarter.
  • PEAK6 Group sold 213,149 MINDRAY MED INTL LTD SPONSORED ADR REPSTG CL A shares in Q1 2016, an estimated $5.78M.
  • PEAK6 Group first reported a position in MINDRAY MED INTL LTD SPONSORED ADR REPSTG CL A in Q4 2013 and held it in 4 quarters.
  • PEAK6 Group's MINDRAY MED INTL LTD SPONSORED ADR REPSTG CL A position peaked at $5.78M in Q4 2015.
  • 2 funds tracked by Wall St. Rank held MINDRAY MED INTL LTD SPONSORED ADR REPSTG CL A as of Q1 2016.

Based on PEAK6 Group's 13F filing for Q1 2016, filed 13 May 2016.